BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22762161)

  • 1. Synthesis and biological evaluation of new sulfonamide derivatives as potential anti-Trypanosoma cruzi agents.
    Bocanegra-Garcia V; Villalobos-Rocha JC; Nogueda-Torres B; Lemus-Hernandez ME; Camargo-Ordonez A; Rosas-Garcia NM; Rivera G
    Med Chem; 2012 Nov; 8(6):1039-44. PubMed ID: 22762161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
    Elizondo-Jimenez S; Moreno-Herrera A; Reyes-Olivares R; Dorantes-Gonzalez E; Nogueda-Torres B; Oliveira EAG; Romeiro NC; Lima LM; Palos I; Rivera G
    Med Chem; 2017; 13(2):149-158. PubMed ID: 27396731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile Synthesis of a Series of Non-Symmetric Thioethers Including a Benzothiazole Moiety and Their Use as Efficient In Vitro anti-
    Avila-Sorrosa A; Tapia-Alvarado JD; Nogueda-Torres B; Chacón-Vargas KF; Díaz-Cedillo F; Vargas-Díaz ME; Morales-Morales D
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31450583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of isoxazolyl-sulfonamides: A non-cytotoxic scaffold active against Trypanosoma cruzi, Leishmania amazonensis and Herpes Simplex Virus.
    da Rosa R; Zimmermann LA; de Moraes MH; Schneider NFZ; Schappo AD; Simões CMO; Steindel M; Schenkel EP; Bernardes LSC
    Bioorg Med Chem Lett; 2018 Nov; 28(20):3381-3384. PubMed ID: 30194008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro evaluation of leishmanicidal and trypanocidal activities of N-quinolin-8-yl-arylsulfonamides.
    da Silva LE; Joussef AC; Pacheco LK; da Silva DG; Steindel M; Rebelo RA; Schmidt B
    Bioorg Med Chem; 2007 Dec; 15(24):7553-60. PubMed ID: 17889546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain.
    Roush WR; Cheng J; Knapp-Reed B; Alvarez-Hernandez A; McKerrow JH; Hansell E; Engel JC
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2759-62. PubMed ID: 11591518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the binding envelope of CYP51 inhibitors targeting Trypanosoma cruzi with 4-aminopyridyl-based sulfonamide derivatives.
    Vieira DF; Choi JY; Roush WR; Podust LM
    Chembiochem; 2014 May; 15(8):1111-20. PubMed ID: 24771705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, 2D-QSAR Studies and Biological Evaluation of Quinazoline Derivatives as Potent Anti-Trypanosoma cruzi Agents.
    Bollini M; Bruno AM; Niño ME; Casal JJ; Sasiambarrena LD; Valdez DAG; Battini L; Puente VR; Lombardo ME
    Med Chem; 2019; 15(3):265-276. PubMed ID: 30295191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro, ex vivo and in vivo short-term screening of DHEA nitrate derivatives activity over Trypanosoma cruzi Ninoa and TH strains from Oaxaca State, México.
    Domínguez-Díaz LR; Eugenia Ochoa M; Soto-Castro D; Farfán N; Morales-Chamorro M; Yépez-Mulia L; Pérez-Campos E; Santillan R; Moreno-Rodríguez A
    Bioorg Med Chem; 2021 Oct; 48():116417. PubMed ID: 34571489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, characterization, and sulfonamide and thiol inhibition studies of an α-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease.
    Pan P; Vermelho AB; Capaci Rodrigues G; Scozzafava A; Tolvanen ME; Parkkila S; Capasso C; Supuran CT
    J Med Chem; 2013 Feb; 56(4):1761-71. PubMed ID: 23391336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural design, synthesis and anti-Trypanosoma cruzi profile of the second generation of 4-thiazolidinones chlorine derivatives.
    Bezerra de Oliveira Filho G; Veríssimo de Oliveira Cardoso M; Caroline da Silva Santos A; Ramos Dos Santos TA; Cristovão-Silva AC; Rubio LG; da Silva Maia Neto L; Leite PG; Machado FS; Alves LC; Brayner FA; Alves Pereira VR; Lima Leite AC
    Chem Biol Interact; 2021 Aug; 345():109514. PubMed ID: 34023282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in vitro and in vivo anti-Trypanosoma cruzi and toxicological activities of nitroaromatic Schiff bases.
    Cunha Almeida T; Gonzaga Ribeiro LH; Ferreira Dos Santos LB; da Silva CM; Tupinambá Branquinho R; de Lana M; Ramos Gadelha F; de Fátima Â
    Biomed Pharmacother; 2018 Dec; 108():1703-1711. PubMed ID: 30372873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, molecular docking and biological evaluation of novel phthaloyl derivatives of 3-amino-3-aryl propionic acids as inhibitors of Trypanosoma cruzi trans-sialidase.
    Kashif M; Chacón-Vargas KF; López-Cedillo JC; Nogueda-Torres B; Paz-González AD; Ramírez-Moreno E; Agusti R; Uhrig ML; Reyes-Arellano A; Peralta-Cruz J; Ashfaq M; Rivera G
    Eur J Med Chem; 2018 Aug; 156():252-268. PubMed ID: 30006170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.
    Soares FGN; Göethel G; Kagami LP; das Neves GM; Sauer E; Birriel E; Varela J; Gonçalves IL; Von Poser G; González M; Kawano DF; Paula FR; de Melo EB; Garcia SC; Cerecetto H; Eifler-Lima VL
    BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):76. PubMed ID: 31852548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into Anti-Trypanosomal Agents Based on Synthetic Glycoconjugates.
    Campo VL; Marchiori MF; Carvalho I
    Curr Top Med Chem; 2018; 18(5):382-396. PubMed ID: 29741138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
    Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
    Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of quinones derived from natural product komaroviquinone as anti-Trypanosoma cruzi agents.
    Suto Y; Nakajima-Shimada J; Yamagiwa N; Onizuka Y; Iwasaki G
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2967-71. PubMed ID: 26037321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Antitrypanosomal Profile of Novel Hydrazonoyl Derivatives.
    Santiago NN; de Alcântara GP; da Costa JS; Carvalho SA; Barbosa JMC; Salomão K; de Castro SL; Pereira HMG; da Silva EF
    Med Chem; 2020; 16(4):487-494. PubMed ID: 31309899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
    Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
    Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.